142nd APHA Annual Meeting and Exposition

Home Events & Meetings Annual Meeting Schedule & Program

Online Program

Annual Meeting Recordings are now available for purchase

314584
Translating FDA/CTP Authority into Regulatory Action

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014 : 4:30 PM - 4:50 PM

Mitch Zeller, J.D. , Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD
  
Audio (mp3) recording Recorded Presentation (mp4)
This session will help the public health community understand the authority granted to the U.S. Food and Drug Administration (FDA) to regulate tobacco. FDA staff will describe actions taken by the FDA in the first five years of regulating tobacco products and preview future regulatory priorities. Attendees will learn about specific policy options that they can pursue and understand the different and specific ways in which they can collaborate with and inform FDA’s work. 

Learning Areas:

Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
Explain FDAs Center for Tobacco Products’ (CTP) strategic priorities and CTPs vision for the regulation of tobacco products to help reduce the death and disease toll caused by tobacco use. Discuss the ways the public health community can engage with FDA to participate in tobacco product regulation. Identify opportunities to inform FDA action on tobacco to promote public health.

Keyword(s): Tobacco Control, Regulations

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the director of the Food and Drug Administration’s Center for Tobacco Products. I have 30+ years of regulatory, legislative and communications experience working with federal and state health agencies on public health policy issues. I served as FDAs representative on tobacco issues involving Congress, public health groups and foreign governments. I also served as an official US delegate to the World Health Organization’s Working Group for the Framework Convention on Tobacco Control.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4400.1: Food and Drug Administration (FDA) Regulation of Tobacco Products